• Skip to primary navigation
  • Skip to main content

Research Initiatives and Infrastructure

University of Southern CaliforniaResearch and Innovation
  • Funding
  • Limited Submissions
  • Shared Resources
  • Training
  • Announcements
  • Contact
You are here: Home / Archives for Foundations & Others

Foundations & Others

Breast Cancer Alliance Exceptional Project Grants

Slots: 2

Deadlines

Internal Deadline: Friday, February 17, 2023, 5pm PT

LOI: March 31, 2023 – one-page Letter of Intent and CV due to researchgrants@breastcanceralliance.org.

External Deadline: July 21, 2023, midnight EDT

Award Information

Award Type: Grant

Anticipated Award Amount: 1 year grant for $100,000. Indirect costs, which are included in the $100,000 award, must be limited to 8% of total direct costs.

Who May Serve as PI: Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. 

Link to Award: https://breastcanceralliance.org/how-to-apply (top of the page)

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

  • (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
  • (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

The mission of Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved.

To accomplish this, Breast Cancer Alliance:

  • Funds a diversified portfolio of breast cancer research
  • Funds Breast Surgery Fellowship programs
  • Funds the purchase of equipment for research
  • Provides timely information on breast health and the importance of early detection
  • Supports outreach and case managerial services, education, counseling and mammograms for underserved and underinsured women in mid to southern Connecticut and Westchester County, New York

To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists, including post-docs, whose primary focus is breast cancer research and who are at any stage of their careers, to apply for funding for the Exceptional Project Grant. This grant is open to applicants at institutions within the United States.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Takeda/New York Academy of Sciences Innovators in Science Award: Cancer Immunology

Slots: 1 Early-Career Scientist and 1 Senior Scientist.

Deadlines

Internal Deadline: Friday, February 17, 2023, 5pm PT

Nomination Deadline: Friday, March 31, 2023, 11:59pm ET

Letter of Support Deadline: Friday, April 14, 2023, 11:59pm ET (Letters of Support Due)

Award Information

Award Type: Grant

Anticipated Award Amount: $200,000

Who May Serve as PI: 

Early-Career Scientist

The nominee must:

  • Have been engaged in active research for a length of time of 10 years or less since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a junior level Post-doctoral or Faculty position at an invited academic, government, or non-profit institution or equivalent.
  • Have made impactful research contributions and show exceptional promise for significant future achievement in the Award field.

In the event that an Early-Career Scientist nominee has taken a maternity, paternity, adoptive, family care, military, or extended sick leave (in line with their current institution’s policies) during the 10 years since gaining their doctoral degree or equivalent, they can qualify for an extension of the eligibility timeframe. Instructions regarding how to request an extension are provided at the end of the Guidelines section.

Senior Scientist

The nominee must:

  • Have been engaged in active research for a length of time of more than 10 years since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a senior level Faculty position at an invited academic, government, or non-profit institution or equivalent.
  • Have made multiple, extensive, and impactful research contributions to advance the Award field.

Link to Award: https://www.nyas.org/awards/innovators-in-science-award/

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

  • (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
  • (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

Established in 2016, the Innovators in Science Award is administered by the New York Academy of Sciences and sponsored by Takeda. This global award recognizes a promising Early-Career Scientist’s and an outstanding Senior Scientist’s contributions to biomedical science and is intended to support their commitment to innovative research. Select international institutions are invited to submit nominations. Each winner receives an unrestricted prize of US$200,000 for their excellence in, and commitment to, innovative science that has significantly advanced a rotating focus area. 

The 2024 Innovators in Science Award will recognize achievements in Cancer Immunology. Cancer remains the second-leading cause of death worldwide, and the global burden is expected to rise as the population grows and ages.1 Despite major advances in the drug development pipeline, about only 11% of new cancer therapeutics make it into the clinic.2 This Award recognizes bold, creative scientists seeking to increase our molecular and immunological understanding of cancer and inform novel therapeutic approaches.

Review Criteria:

Early-Career Scientist

  • Quality: The extent to which the work is reliable, valid, credible, and scientifically rigorous.
  • Impact: The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
  • Novelty: The extent to which the work challenges existing paradigms, employs innovative new methodologies or concepts, and/or pursues an original question.
  • Promise: The extent to which the nominee has made innovative research contributions and shows exceptional promise for significant future achievement in the Award field.

Senior Scientist

  • Quality: The extent to which the work is reliable, valid, credible, and scientifically rigorous.
  • Impact: The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
  • Novelty: The extent to which the work challenges existing paradigms, employs new innovative methodologies or concepts, and/or pursues an original question.
  • Promise: The extent to which the nominee has made impactful research contributions and future prospects for further significant contributions in the Award field.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

CDC RFA-PS-23-006: Identifying and Addressing Historical and Structural Drivers of Medical Mistrust among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex with Men (HLMSM) for HIV Prevention

Slots: 1

Deadlines

Internal Deadline: Contact RII.

LOI: N/A

External Deadline: February 23, 2023

Award Information

Award Type: Cooperative Agreement

Estimated Number of Awards: 3

Anticipated Award Amount: $7,500,000

Who May Serve as PI:  Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Project Director/Principal Investigator (PD/PI) is invited to work with his/her
organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for HHS/CDC support.

Link to Award: https://www.grants.gov/web/grants/view-opportunity.html?oppId=343404

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

  • (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
  • (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

CDC supports efforts to improve the health of populations disproportionately affected by
infectious diseases by maximizing the health impact of public health services, reducing disease
incidence, and advancing health equity.
A health disparity occurs when a health outcome is seen to a greater or lesser extent between
populations. Health disparities in infectious diseases are inextricably linked to a complex blend
of social determinants that influence which populations are most disproportionately affected by
these infections and diseases.
Social determinants are conditions in the places where people live, learn, work, and play that
affect a wide range of health and quality-of life-risks and outcomes
(https://www.cdc.gov/socialdeterminants/index.htm). These include conditions for early
childhood development; education, employment, and work; food security, health services,
housing, income, and social exclusion. Health equity is a desirable goal that entails special
efforts to improve the health of those who have experienced social or economic challenges. It
requires:
 Continuous efforts focused on elimination of health disparities, including disparities in
health and in the living and working conditions that influence health, and
 Continuous efforts to maintain a desired state of equity after health disparities are
eliminated.
Applicants should use data, including social determinants data, to identify communities within
their jurisdictions that are disproportionately affected by infectious diseases and related diseases
and conditions, and plan activities to help eliminate health disparities. In collaboration with
partners and appropriate sectors of the community, applicants should consider social
determinants of health in the development, implementation, and evaluation of specific efforts and
use culturally appropriate interventions and strategies that are tailored for the communities for
which they are intended.
Healthy People 2030 and other National Strategic Priorities
Several Healthy People 2030 objectives are supported through this NOFO:
 HIV-1 Reduce the number of new HIV diagnoses among adolescents and adults
 Increase knowledge of HIV status
 HIV-2 Increase the proportion of persons who know their HIV status
 HIV-3 Reduce the number of new HIV diagnoses
 HIV-4 Increase the proportion of persons aged 13 years and over with newly diagnosed
HIV infection linked to HIV medical care within 1 month
 Increase HIV testing and prevent HIV risk
 HIV-13 Increase the proportion of persons with HIV who know their serostatus
 HIV-17 Increase the proportion of sexually active persons who use condoms
 HIV-19 Increase the percentage of persons with newly diagnosed HIV infection linked to
HIV
 SDOH-R01 Increase the proportion of federal data sources that collect country of birth as
a variable
 PHI-R07 Explore the use and impact of quality improvement as a means for increasing
efficiency and/or effectiveness outcomes in health departments
This NOFO also supports HIV National Strategic Plan (2022-2025) goals.
Goal 1: Prevent New HIV Infections
 1.3.4 Implement culturally competent and linguistically appropriate models and other
innovative approaches for delivering HIV prevention services.
 1.3.5 Support research into the development and evaluation of new HIV prevention
modalities and interventions for preventing HIV transmissions in priority populations.
Page 11 of 58
 1.3.6 Expand implementation research to successfully adapt evidence-based interventions
to local environments to maximize potential for uptake and sustainability.
Goal 3: Reduce HIV-Related Disparities and Health Inequities
 3.1.1 Strengthen enforcement of civil rights laws (including language access services and
disability rights), promote reform of state HIV criminalization laws, and assist states in
protecting people with HIV from violence, retaliation, and discrimination associated with
HIV status, homophobia, transphobia, xenophobia, racism, substance use, and sexism.
 3.1.2 Ensure that health care professionals and front-line staff complete education and
training on stigma, discrimination, and unrecognized bias toward populations with or
who experience risk for HIV, including LGBTQI+ people, immigrants, people who use
drugs, and people involved in sex work.
 3.1.3 Support communities in efforts to address misconceptions and reduce HIV-related
stigma and other stigmas that negatively affect HIV outcomes.
 3.1.4 Ensure resources are focused on the communities and populations where the need is
greatest, especially Black, Latino, and American Indian/Alaska Native and other people
of color, particularly those who are also gay and bisexual men, transgender people,
people who use substances, sex workers, and immigrants.
 3.1.5 Create funding opportunities that specifically address social and structural drivers
of health as they relate to Black, Latino, and American Indian/Alaska Native and other
people of color.
 3.4.4 Develop and implement effective, evidence-based, and evidence-informed
interventions that address social and structural determinants of health among people with
or who experience risk for HIV including lack of continuous health care coverage, HIVrelated stigma and discrimination in public health and health care systems, medical
mistrust, inadequate housing and transportation, food insecurity, unemployment, low
health literacy, and involvement with the justice system.
 3.5 Expand effective communication strategies between providers and consumers to build
trust, optimize collaborative decision-making, and promote success of evidence-based
prevention and treatment strategies.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Department of Energy/EERE AMMTO-BTO and OE FY22 Multi-Topic FOA (DE-FOA-0002864)

Slots: 1

Deadlines

Internal Deadline: Contact RII.

LOI: February 3, 2023

External Deadline: April 7, 2023

Award Information

Award Type: Cooperative Agreement

Estimated Number of Awards: 18-36

Anticipated Award Amount: $52 million

Who May Serve as PI: 

The proposed prime recipient and subrecipient(s) must be domestic entities. The
following types of domestic entities are eligible to participate as a prime
recipient or subrecipient of this FOA:

  1. Institutions of higher education;
  2. For-profit entities;
  3. Non-profit entities; and
  4. State and local governmental entities, and tribal nations.

Link to Award: https://eere-exchange.energy.gov/Default.aspx#FoaId2e455119-5dd2-4824-876d-f803cea5696c

Cost Share: The cost share must be at least 20% of the total allowable costs for research and development projects (i.e., the sum of the government share, including FFRDC costs if applicable, and the recipient share of allowable costs equals the total allowable cost of the project) and must come from non-federal sources unless otherwise allowed by law.

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

  • (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
  • (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

This multitopic FOA is a joint effort between EERE’s Advanced Materials and Manufacturing Technologies Office (AMMTO), the Building Technologies Office (BTO), and DOE’s Office of Electricity (OE). The mission of AMMTO is to advance energy-related materials and manufacturing technologies to increase domestic competitiveness and build a clean, decarbonized economy. This is in alignment with AMMTO’s vision for the future – a competitive U.S. manufacturing sector that accelerates the adoption of innovative material and manufacturing technologies in support of a clean, decarbonized economy. Until October 9,
2022, the relevant workshops and prior research highlighted in the various subtopic descriptions below were supported by EERE’s Advanced Manufacturing Office (AMO). On October 9, AMO officially split into two offices within EERE: the Industrial Efficiency and Decarbonization Office (IEDO) and AMMTO.


BTO develops, demonstrates, and accelerates the adoption of cost-effective technologies, techniques, tools and services that enable high-performing, energy-efficient and demand-flexible residential and commercial buildings in both the new and existing buildings markets, in support of an equitable
transition to a decarbonized energy system by 2050, starting with a decarbonized power sector by 2035.


OE provides national leadership to ensure that the Nation’s energy delivery system is secure, resilient, and reliable. Through research and development, OE develops new technologies to improve the infrastructure that effectively and securely brings electricity into our homes, offices, and factories, and also
oversees the Federal and state electricity policies and programs that shape electricity system planning and market operations. Specifically, the goals of this multi-topic FOA are to:
1) Validate and demonstrate next generation materials and manufacturing processes including domestic pilot demonstrations and related technologies to support the transition to U.S. manufacturing;
2) Enable environmentally and socially responsible domestic manufacturing with diversified domestic supply of feedstocks including from recycled goods; and

3) Mature nascent technologies, processes, and methods that improve the performance and market penetration of clean energy technologies and emerging building efficiency technologies.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Department of Energy DE-FOA-0002942: Advanced Scientific Computing Research – Reaching a New Energy Sciences Workforce (ASCR-RENEW)

Slots: 3

Deadlines

Internal Deadline: Contact RII.

LOI: February 21, 2023

External Deadline: April 18, 2023

Award Information

Award Type: Grant

Estimated Number of Awards: The exact number of awards will depend on the number of meritorious applications and the availability of appropriated funds.

Anticipated Award Amount: Between $50,000 and $1,000,000 per year.

Who May Serve as PI: Individuals with the skills, knowledge, and resources necessary to carry out the proposed project as a Principal Investigator (PI) are invited to work with their organizations to develop an
application. Individuals from underrepresented groups as well as individuals with disabilities are always encouraged to apply.

Link to Award: https://www.grants.gov/custom/viewOppDetails.jsp?oppId=345283

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

  • (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
  • (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

Reaching a New Energy Sciences Workforce (RENEW) aims to build foundations for Office of Science (SC) research and training at institutions historically underrepresented in the SC research portfolio. RENEW leverages SC’s unique national laboratories, user facilities, and other research infrastructures to provide undergraduate and graduate training opportunities for students and academic institutions not currently well represented in the U.S. science and technology (S&T) ecosystem. The hands-on experiences gained through RENEW will open new career avenues for participants, forming a nucleus for a future pool of talented young scientists, engineers, and technicians with the critical skills and expertise needed for the full breadth of SC research activities. Principal Investigators, key personnel, and students and postdocs of RENEW awards will be invited to participate in ASCR researcher meetings and/or SC-wide professional
development and collaborator events.
The goal of ASCR’s RENEW program is to increase participation of underrepresented groups in the advanced scientific computing workforce and to increase participation of underrepresented institutions in advanced scientific computing workforce training. ASCR announces its interest in receiving applications for collaborative projects to enhance training opportunities for students and postdoctoral researchers from underrepresented groups and at institutions that are currently underrepresented in the ASCR portfolio such as non-R12 institutions of higher education and minority serving institutions, including Historically Black Colleges and Universities.
SUPPLEMENTARY INFORMATION
Program Objective
ASCR’s mission is to advance applied mathematics and computer science; deliver the most advanced computational scientific applications in partnership with disciplinary science; advance computing and networking capabilities; and develop future generations of computing hardware and software tools for science and engineering, in partnership with the research community, including U.S. industry. The ASCR program gives the science and technology community, including U.S. industry, access to world-class supercomputers and the tools to use them for science and engineering. ASCR accomplishes this by developing and maintaining world-class computing and network facilities for science; and advancing research in applied mathematics, computer science, and advanced networking.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Agilent Early Career Professor Award (ACA)

Slots: As per Agilent: “We invite many top universities to nominate one candidate. Of course, if your university is so fortunate as to have two world-leading early career professors in the area of this call, please do nominate both.”

Deadlines

Internal Deadline: Contact RII.

LOI: N/A

External Deadline: February 24, 2023 to university_relations@agilent.com

Award Information

Award Type: Grant

Anticipated Award Amount: An unrestricted research award of $120,000 to be distributed in 2 years to university in the professor’s name. (Option to use all or part of award to obtain Agilent products at 50% discount; option to accelerate payments to facilitate procurement of equipment with list price over $120,000).

Who May Serve as PI: 

  • Professor must hold a tenure-tracked faculty position
  • Must have completed Ph.D. or M.D. residency within 12 years of award year
    (additional extensions may apply, please see FAQ)

Link to Award: https://www.agilent.com/univ_relation/profaward/index.shtml

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

  • (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
  • (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

The purpose of the Agilent Early Career Professor Award is to:
  • Promote and encourage excellent research enabling measurements of importance to Agilent Technologies and the world
  • Establish strong collaborative relationships between Agilent researchers and leading professors early in their career
  • Build the prominence of Agilent as a sponsor of university research
Selection Criteria
  • Significant original research contributions enabling measurements of importance to Agilent Technologies and the world
  • Outstanding potential for future research
  • Professor completed Ph.D. (residency in case of M.D.’s or M.D. Ph.D’s) not earlier than January 2012. See FAQ
  • Alignment with the 2022 Focus: Contributions to the development of live cell analytical tools to identify and measure novel critical quality attributes (CQA) to advance biomanufacturing applications.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

« Previous Page
Next Page »

Research Initiatives and Infrastructure
Third Floor, 3720 Flower St, Los Angeles, CA 90007
rii@usc.edu

University of Southern California   Content managed by RII
  • Privacy Notice - Notice of Non-Discrimination